| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |